Abstract:Ischemic stroke is caused by cerebrovascular stenosis or occlusion. The excessive reactive oxygen species (ROS) are the focus‐triggering factor of irreversible injury in the ischemic regions, which result the harmful cascading‐effects to brain tissue such as inflammation and microthrombus formation. In the present work, we designed a nanodelivery systems (NDSs) based on MnO 2 loaded with Ginkgolide B (GB) for restoring the intracerebral microenvironment in ischemic stroke, such as ROS scavenging, O 2 elevation, thrombus inhibition and damage repair. GB can activate the endogenous antioxidant defense of cells by enhancing the nuclear factor‐E2‐related factor 2 (Nrf2) signal pathway, thus protecting brain tissue from oxidative damage. However, the blood‐brain barrier (BBB) is also therapeutic obstacles for agent's delivery to ischemic regions. MnO 2 nanoparticle has an inherent BBB penetration effect, which enhances the delivery of therapeutic agents within brain tissue. MnO 2 with mimic enzymatic activity can catalyze the overproduced H 2 O 2 in the ischemic microenvironment to produce O 2 and meanwhile release platelets antagonist GB molecules, thus alleviating cerebral hypoxia, oxidative stress damage and microthrombus generation. This study may provide a promising therapeutic routine for regulating the microenvironment of ischemic stroke through a combined function of ROS scavenging, microthrombus inhibition, and BBB penetration.

Thrombus inhibition and neuroprotection for ischemic stroke treatment through platelet regulation and ROS scavenging